Company / Cash & Equivalents
Global Medical REIT Inc. Cash & Equivalents History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$6.8M
FY2024
5-year range
$1.3M / $7.2M
FY2020-FY2024
Trend
+433.3%
vs FY2023
Sector context
#123 of 132
Real Estate
What the data says
Cash & Equivalents changed +433% YoY in FY2024, a notable deviation from the 9-year average annual change of +49%.
Based on SEC 10-K filings.
$7M in FY2024 with a 5-year CAGR of +19.8%.
Improved from $4M to $7M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +19.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Real EstateTop 93% of 132This company $6.8M Sector average $340.0M
▼
-98.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.8%, indicating consistent growth.
- In FY2024, cash & equivalents increased 433.3% year-over-year.
- Ranks #123 out of 132 companies in the Real Estate sector.
- Peak cash & equivalents was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.8M | +433.3% |
| FY2023 | $1.3M | -68.2% |
| FY2022 | $4.0M | -44.3% |
| FY2021 | $7.2M | +31.0% |
| FY2020 | $5.5M | +99.2% |
| FY2019 | $2.8M | -23.9% |
| FY2018 | $3.6M | -28.9% |
| FY2017 | $5.1M | -74.0% |
| FY2016 | $19.7M | +114.2% |
| FY2015 | $9.2M | +10219.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026